Works matching IS 00099104 AND DT 2020 AND VI 200 AND IP 2

Results: 11

Immune checkpoint inhibition: from molecules to clinical application.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 105, doi. 10.1111/cei.13434
By:
- Taams, L. S.;
- Gruijl, T. D.
Publication type:
Article
Role of inflammasome activation in tumor immunity triggered by immune checkpoint blockers.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 155, doi. 10.1111/cei.13433
By:
- Segovia, M.;
- Russo, S.;
- Girotti, M. R.;
- Rabinovich, G. A.;
- Hill, M.
Publication type:
Article
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 131, doi. 10.1111/cei.13424
By:
- Quandt, Z.;
- Young, A.;
- Anderson, M.
Publication type:
Article
MAIT cell activation in adolescents is impacted by bile acid concentrations and body weight.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 199, doi. 10.1111/cei.13423
By:
- Mendler, A.;
- Pierzchalski, A.;
- Bauer, M.;
- Röder, S.;
- Sattler, A.;
- Standl, M.;
- Borte, M.;
- Bergen, M.;
- Rolle‐Kampczyk, U.;
- Herberth, G.
Publication type:
Article
Mechanisms of checkpoint inhibition‐induced adverse events.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 141, doi. 10.1111/cei.13421
By:
- Urwyler, P.;
- Earnshaw, I.;
- Bermudez, M.;
- Perucha, E.;
- Wu, W.;
- Ryan, S.;
- Mcdonald, L.;
- Karagiannis, S. N.;
- Taams, L. S.;
- Powell, N.;
- Cope, A.;
- Papa, S.
Publication type:
Article
Comparison of elapegademase and pegademase in ADA‐deficient patients and mice.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 176, doi. 10.1111/cei.13420
By:
- Murguia‐Favela, L.;
- Min, W.;
- Loves, R.;
- Leon‐Ponte, M.;
- Grunebaum, E.
Publication type:
Article
High activation and skewed T cell differentiation are associated with low IL‐17A levels in a hu‐PBL‐NSG‐SGM3 mouse model of HIV infection.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 185, doi. 10.1111/cei.13416
By:
- Perdomo‐Celis, F.;
- Medina‐Moreno, S.;
- Davis, H.;
- Bryant, J.;
- Taborda, N. A.;
- Rugeles, M. T.;
- Kottilil, S.;
- Zapata, J. C.
Publication type:
Article
VISTA: Coming of age as a multi‐lineage immune checkpoint.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 120, doi. 10.1111/cei.13415
By:
- ElTanbouly, M. A.;
- Schaafsma, E.;
- Noelle, R. J.;
- Lines, J. L.
Publication type:
Article
Phenotypic shift of small intestinal intra‐epithelial type 1 innate lymphoid cells in celiac disease is associated with enhanced cytotoxic potential.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 163, doi. 10.1111/cei.13414
By:
- Uhde, M.;
- Yu, X.;
- Bunin, A.;
- Brauner, C.;
- Lewis, S. K.;
- Lebwohl, B.;
- Krishnareddy, S.;
- Alaedini, A.;
- Reizis, B.;
- Ghosh, S.;
- Green, P. H.;
- Bhagat, G.
Publication type:
Article
TIGIT as an emerging immune checkpoint.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 108, doi. 10.1111/cei.13407
By:
- Harjunpää, H.;
- Guillerey, C.
Publication type:
Article
Issue Information.
Published in:
Clinical & Experimental Immunology, 2020, v. 200, n. 2, p. 1, doi. 10.1111/cei.13321
Publication type:
Article